[English] 日本語
Yorodumi
- PDB-7ugb: Crystal structure of rat ERK2 complexed with docking peptide from... -

+
Open data


ID or keywords:

Loading...

-
Basic information

Entry
Database: PDB / ID: 7ugb
TitleCrystal structure of rat ERK2 complexed with docking peptide from ISG20
Components
  • Interferon-stimulated gene 20 kDa protein
  • Mitogen-activated protein kinase 1
KeywordsSIGNALING PROTEIN / kinase / complex / docking
Function / homology
Function and homology information


exoribonuclease II / exoribonuclease II activity / phospho-PLA2 pathway / RAF-independent MAPK1/3 activation / MAPK1 (ERK2) activation / Signaling by NODAL / Frs2-mediated activation / ERK/MAPK targets / ERKs are inactivated / Activation of the AP-1 family of transcription factors ...exoribonuclease II / exoribonuclease II activity / phospho-PLA2 pathway / RAF-independent MAPK1/3 activation / MAPK1 (ERK2) activation / Signaling by NODAL / Frs2-mediated activation / ERK/MAPK targets / ERKs are inactivated / Activation of the AP-1 family of transcription factors / RHO GTPases Activate WASPs and WAVEs / Transcriptional and post-translational regulation of MITF-M expression and activity / Negative feedback regulation of MAPK pathway / Gastrin-CREB signalling pathway via PKC and MAPK / Estrogen-dependent nuclear events downstream of ESR-membrane signaling / IFNG signaling activates MAPKs / Golgi Cisternae Pericentriolar Stack Reorganization / Estrogen-stimulated signaling through PRKCZ / Regulation of actin dynamics for phagocytic cup formation / Growth hormone receptor signaling / Spry regulation of FGF signaling / SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription / Oxidative Stress Induced Senescence / Senescence-Associated Secretory Phenotype (SASP) / Oncogene Induced Senescence / Signaling by Activin / Downregulation of SMAD2/3:SMAD4 transcriptional activity / Signal attenuation / NCAM signaling for neurite out-growth / Negative regulation of FGFR1 signaling / Negative regulation of FGFR3 signaling / Negative regulation of FGFR4 signaling / Regulation of the apoptosome activity / Negative regulation of FGFR2 signaling / Signal transduction by L1 / RHO GTPases Activate NADPH Oxidases / Negative regulation of MAPK pathway / PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling / Interferon gamma signaling / FCERI mediated MAPK activation / Regulation of HSF1-mediated heat shock response / diadenosine tetraphosphate biosynthetic process / MAP2K and MAPK activation / Recycling pathway of L1 / neural crest cell development / response to alcohol / cellular response to toxic substance / cellular response to methionine / single-stranded DNA 3'-5' DNA exonuclease activity / cardiac neural crest cell development involved in heart development / caveolin-mediated endocytosis / mitogen-activated protein kinase kinase kinase binding / cytosine metabolic process / response to epidermal growth factor / DNA catabolic process / positive regulation of macrophage proliferation / RNA catabolic process / outer ear morphogenesis / regulation of cellular pH / regulation of Golgi inheritance / RAF/MAP kinase cascade / Thrombin signalling through proteinase activated receptors (PARs) / ERBB signaling pathway / U3 snoRNA binding / exonuclease activity / labyrinthine layer blood vessel development / Neutrophil degranulation / mammary gland epithelial cell proliferation / trachea formation / regulation of early endosome to late endosome transport / negative regulation of viral genome replication / regulation of stress-activated MAPK cascade / cellular response to insulin-like growth factor stimulus / positive regulation of macrophage chemotaxis / ERBB2-ERBB3 signaling pathway / lung morphogenesis / response to exogenous dsRNA / regulation of cytoskeleton organization / face development / androgen receptor signaling pathway / cellular response to platelet-derived growth factor stimulus / pseudopodium / response to testosterone / positive regulation of telomere capping / Bergmann glial cell differentiation / thyroid gland development / negative regulation of cell differentiation / decidualization / steroid hormone receptor signaling pathway / MAP kinase activity / regulation of ossification / estrous cycle / mitogen-activated protein kinase / phosphatase binding / U2 snRNA binding / progesterone receptor signaling pathway / Schwann cell development / Cajal body / stress-activated MAPK cascade / U1 snRNA binding
Similarity search - Function
: / Exonuclease / Exonuclease, RNase T/DNA polymerase III / EXOIII / Mitogen-activated protein (MAP) kinase, ERK1/2 / Mitogen-activated protein (MAP) kinase, conserved site / MAP kinase signature. / : / Ribonuclease H superfamily / Ribonuclease H-like superfamily ...: / Exonuclease / Exonuclease, RNase T/DNA polymerase III / EXOIII / Mitogen-activated protein (MAP) kinase, ERK1/2 / Mitogen-activated protein (MAP) kinase, conserved site / MAP kinase signature. / : / Ribonuclease H superfamily / Ribonuclease H-like superfamily / Serine/threonine-protein kinase, active site / Serine/Threonine protein kinases active-site signature. / Protein kinase domain / Serine/Threonine protein kinases, catalytic domain / Protein kinase, ATP binding site / Protein kinases ATP-binding region signature. / Protein kinase domain profile. / Protein kinase domain / Protein kinase-like domain superfamily
Similarity search - Domain/homology
PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER / Mitogen-activated protein kinase 1 / Interferon-stimulated gene 20 kDa protein
Similarity search - Component
Biological speciesRattus norvegicus (Norway rat)
Homo sapiens (human)
MethodX-RAY DIFFRACTION / SYNCHROTRON / MOLECULAR REPLACEMENT / molecular replacement / Resolution: 1.9 Å
AuthorsTorres Robles, J. / Stiegler, A.L. / Boggon, T.J. / Turk, B.E.
Funding support United States, 2items
OrganizationGrant numberCountry
National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS)R01 GM135331 United States
National Science Foundation (NSF, United States)1752134 United States
CitationJournal: To Be Published
Title: To be determined
Authors: Torres Robles, J. / Turk, B.E.
History
DepositionMar 24, 2022Deposition site: RCSB / Processing site: RCSB
Revision 1.0Mar 29, 2023Provider: repository / Type: Initial release
Revision 1.1Oct 25, 2023Group: Data collection / Refinement description
Category: chem_comp_atom / chem_comp_bond / pdbx_initial_refinement_model
Revision 1.2Oct 23, 2024Group: Structure summary / Category: pdbx_entry_details / pdbx_modification_feature / Item: _pdbx_entry_details.has_protein_modification

-
Structure visualization

Structure viewerMolecule:
MolmilJmol/JSmol

Downloads & links

-
Assembly

Deposited unit
A: Mitogen-activated protein kinase 1
I: Interferon-stimulated gene 20 kDa protein
hetero molecules


Theoretical massNumber of molelcules
Total (without water)45,8363
Polymers45,3302
Non-polymers5061
Water2,630146
1


  • Idetical with deposited unit
  • defined by author&software
TypeNameSymmetry operationNumber
identity operation1_555x,y,z1
Buried area2450 Å2
ΔGint-6 kcal/mol
Surface area16440 Å2
MethodPISA
Unit cell
Length a, b, c (Å)45.888, 66.679, 116.969
Angle α, β, γ (deg.)90.000, 90.000, 90.000
Int Tables number19
Space group name H-MP212121

-
Components

#1: Protein Mitogen-activated protein kinase 1 / MAP kinase 1 / MAPK 1 / ERT1 / Extracellular signal-regulated kinase 2 / ERK-2 / MAP kinase isoform ...MAP kinase 1 / MAPK 1 / ERT1 / Extracellular signal-regulated kinase 2 / ERK-2 / MAP kinase isoform p42 / p42-MAPK / Mitogen-activated protein kinase 2 / MAP kinase 2 / MAPK 2


Mass: 43720.176 Da / Num. of mol.: 1
Source method: isolated from a genetically manipulated source
Details: Unphosphorylated / Source: (gene. exp.) Rattus norvegicus (Norway rat) / Gene: Mapk1, Erk2, Mapk, Prkm1 / Production host: Escherichia coli BL21(DE3) (bacteria)
References: UniProt: P63086, mitogen-activated protein kinase
#2: Protein/peptide Interferon-stimulated gene 20 kDa protein / Estrogen-regulated transcript 45 protein / Promyelocytic leukemia nuclear body-associated protein ISG20


Mass: 1609.920 Da / Num. of mol.: 1 / Source method: obtained synthetically / Source: (synth.) Homo sapiens (human) / References: UniProt: Q96AZ6, exoribonuclease II
#3: Chemical ChemComp-ANP / PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER


Mass: 506.196 Da / Num. of mol.: 1 / Source method: obtained synthetically / Formula: C10H17N6O12P3 / Comment: AMP-PNP, energy-carrying molecule analogue*YM
#4: Water ChemComp-HOH / water


Mass: 18.015 Da / Num. of mol.: 146 / Source method: isolated from a natural source / Formula: H2O
Has ligand of interestN
Has protein modificationY

-
Experimental details

-
Experiment

ExperimentMethod: X-RAY DIFFRACTION / Number of used crystals: 1

-
Sample preparation

CrystalDensity Matthews: 1.97 Å3/Da / Density % sol: 37.68 %
Crystal growTemperature: 293 K / Method: vapor diffusion, hanging drop / pH: 7.5
Details: 10 % PEG 4000, 0.1 M HEPES [pH 7.5] and 5 % Isopropanol

-
Data collection

DiffractionMean temperature: 100 K / Serial crystal experiment: N
Diffraction sourceSource: SYNCHROTRON / Site: APS / Beamline: 24-ID-E / Wavelength: 0.97918 Å
DetectorType: DECTRIS EIGER X 16M / Detector: PIXEL / Date: Apr 14, 2020
RadiationProtocol: SINGLE WAVELENGTH / Monochromatic (M) / Laue (L): M / Scattering type: x-ray
Radiation wavelengthWavelength: 0.97918 Å / Relative weight: 1
ReflectionResolution: 1.9→50 Å / Num. obs: 29145 / % possible obs: 100 % / Redundancy: 23.7 % / Biso Wilson estimate: 34.8 Å2 / Rmerge(I) obs: 0.127 / Rpim(I) all: 0.026 / Rrim(I) all: 0.13 / Χ2: 0.933 / Net I/σ(I): 6.6 / Num. measured all: 692189
Reflection shell

Diffraction-ID: 1 / % possible all: 100

Resolution (Å)Redundancy (%)Rmerge(I) obsNum. unique obsCC1/2Rpim(I) allRrim(I) allΧ2
1.9-1.9715.41.24428660.8280.3081.2840.63
1.97-2.0518.70.99628300.9330.2291.0220.667
2.05-2.1421.70.75328760.9520.1620.770.729
2.14-2.2525.10.59928750.9810.1210.6110.809
2.25-2.3926.90.45728900.9890.0890.4660.879
2.39-2.5826.70.33228880.9920.0650.3381.02
2.58-2.8425.90.22129010.9960.0440.2261.065
2.84-3.2524.80.14329350.9970.0290.1461.096
3.25-4.0927.50.09529520.9990.0180.0971.079
4.09-5024.50.06931320.9990.0140.071.093

-
Phasing

PhasingMethod: molecular replacement
Phasing MR
Highest resolutionLowest resolution
Rotation5.31 Å43.97 Å
Translation5.31 Å43.97 Å

-
Processing

Software
NameVersionClassification
HKL-2000721.2data scaling
PHASER2.8.3phasing
PHENIX1.19.2refinement
PDB_EXTRACT3.27data extraction
HKL-2000721.2data reduction
RefinementMethod to determine structure: MOLECULAR REPLACEMENT
Starting model: 4FMQ

4fmq


Resolution: 1.9→43.97 Å / SU ML: 0.22 / Cross valid method: THROUGHOUT / σ(F): 1.36 / Phase error: 22.19 / Stereochemistry target values: ML
RfactorNum. reflection% reflection
Rfree0.2276 1451 5 %
Rwork0.1792 27569 -
obs0.1815 29020 99.93 %
Solvent computationShrinkage radii: 0.9 Å / VDW probe radii: 1.11 Å / Solvent model: FLAT BULK SOLVENT MODEL
Displacement parametersBiso max: 119.12 Å2 / Biso mean: 47.4003 Å2 / Biso min: 21.01 Å2
Refinement stepCycle: final / Resolution: 1.9→43.97 Å
ProteinNucleic acidLigandSolventTotal
Num. atoms2835 0 31 146 3012
Biso mean--49.71 45.26 -
Num. residues----348
LS refinement shell

Refine-ID: X-RAY DIFFRACTION / Rfactor Rfree error: 0 / Total num. of bins used: 10

Resolution (Å)Rfactor RfreeNum. reflection RfreeRfactor RworkNum. reflection RworkNum. reflection all% reflection obs (%)
1.9-1.970.27131380.23772686282499
1.97-2.050.27261490.228526782827100
2.05-2.140.26241360.209527402876100
2.14-2.250.24481510.193227192870100
2.25-2.390.24191610.227242885100
2.39-2.580.25121590.199127162875100
2.58-2.840.26251340.200627592893100
2.84-3.250.23621310.193427972928100
3.25-4.090.2091400.15727992939100
4.09-43.970.20261520.159429513103100
Refinement TLS params.

Method: refined / Refine-ID: X-RAY DIFFRACTION

IDL11 (°2)L12 (°2)L13 (°2)L22 (°2)L23 (°2)L33 (°2)S11 (Å °)S12 (Å °)S13 (Å °)S21 (Å °)S22 (Å °)S23 (Å °)S31 (Å °)S32 (Å °)S33 (Å °)T11 (Å2)T12 (Å2)T13 (Å2)T22 (Å2)T23 (Å2)T33 (Å2)Origin x (Å)Origin y (Å)Origin z (Å)
15.93470.28980.77263.6106-1.4793.5021-0.1591-0.67341.2634-0.3147-0.34570.4659-1.1337-0.48670.3710.6610.1422-0.13590.504-0.17410.5848-19.1331-0.90167.8408
27.34861.92960.57967.6873-2.36144.86830.07610.15930.1598-0.343-0.2475-0.2783-0.51210.31640.36330.39820.03170.03760.2766-0.0090.2336-5.8679-11.965710.4389
31.6926-0.35260.57533.3124-0.53663.2360.00990.12080.1433-0.2074-0.08780.1331-0.3114-0.02540.050.2210.0164-0.00910.1979-0.03390.2685-12.5352-13.106217.5699
45.72691.59371.61032.84580.47581.49090.1448-0.3618-0.04860.2154-0.1102-0.13480.01980.0888-0.04570.2331-0.0070.02570.24160.0160.2131-1.0738-16.468137.0133
52.46170.5654-0.72348.0146-3.1299.07520.02730.0916-0.48310.00230.01960.27361.26-0.1317-0.07750.36180.0011-0.04240.1824-0.010.3832-12.271-32.862125.0651
61.23450.8565-1.09518.1696-5.00636.2730.10170.253-0.0351-0.7675-0.577-1.1692-0.12380.74390.35030.4574-0.00380.08020.54020.00130.3844-0.6677-10.40094.0154
73.7333-4.041-5.93934.30176.41819.354-0.12480.8073-1.1439-0.1221-0.73752.43820.2415-1.9510.76030.4639-0.0181-0.02460.6188-0.06711.0035-26.738-27.340321.0526
Refinement TLS group
IDRefine-IDRefine TLS-IDSelection detailsAuth asym-IDAuth seq-ID
1X-RAY DIFFRACTION1chain 'A' and (resid 11 through 61 )A11 - 61
2X-RAY DIFFRACTION2chain 'A' and (resid 62 through 85 )A62 - 85
3X-RAY DIFFRACTION3chain 'A' and (resid 86 through 189 )A86 - 189
4X-RAY DIFFRACTION4chain 'A' and (resid 190 through 303 )A190 - 303
5X-RAY DIFFRACTION5chain 'A' and (resid 304 through 321 )A304 - 321
6X-RAY DIFFRACTION6chain 'A' and (resid 322 through 356 )A322 - 356
7X-RAY DIFFRACTION7chain 'I' and (resid 168 through 181 )I168 - 181

+
About Yorodumi

-
News

-
Feb 9, 2022. New format data for meta-information of EMDB entries

New format data for meta-information of EMDB entries

  • Version 3 of the EMDB header file is now the official format.
  • The previous official version 1.9 will be removed from the archive.

Related info.:EMDB header

External links:wwPDB to switch to version 3 of the EMDB data model

-
Aug 12, 2020. Covid-19 info

Covid-19 info

URL: https://pdbj.org/emnavi/covid19.php

New page: Covid-19 featured information page in EM Navigator.

Related info.:Covid-19 info / Mar 5, 2020. Novel coronavirus structure data

+
Mar 5, 2020. Novel coronavirus structure data

Novel coronavirus structure data

Related info.:Yorodumi Speices / Aug 12, 2020. Covid-19 info

External links:COVID-19 featured content - PDBj / Molecule of the Month (242)：Coronavirus Proteases

+
Jan 31, 2019. EMDB accession codes are about to change! (news from PDBe EMDB page)

EMDB accession codes are about to change! (news from PDBe EMDB page)

  • The allocation of 4 digits for EMDB accession codes will soon come to an end. Whilst these codes will remain in use, new EMDB accession codes will include an additional digit and will expand incrementally as the available range of codes is exhausted. The current 4-digit format prefixed with “EMD-” (i.e. EMD-XXXX) will advance to a 5-digit format (i.e. EMD-XXXXX), and so on. It is currently estimated that the 4-digit codes will be depleted around Spring 2019, at which point the 5-digit format will come into force.
  • The EM Navigator/Yorodumi systems omit the EMD- prefix.

Related info.:Q: What is EMD? / ID/Accession-code notation in Yorodumi/EM Navigator

External links:EMDB Accession Codes are Changing Soon! / Contact to PDBj

+
Jul 12, 2017. Major update of PDB

Major update of PDB

  • wwPDB released updated PDB data conforming to the new PDBx/mmCIF dictionary.
  • This is a major update changing the version number from 4 to 5, and with Remediation, in which all the entries are updated.
  • In this update, many items about electron microscopy experimental information are reorganized (e.g. em_software).
  • Now, EM Navigator and Yorodumi are based on the updated data.

External links:wwPDB Remediation / Enriched Model Files Conforming to OneDep Data Standards Now Available in the PDB FTP Archive

-
Yorodumi

Thousand views of thousand structures

  • Yorodumi is a browser for structure data from EMDB, PDB, SASBDB, etc.
  • This page is also the successor to EM Navigator detail page, and also detail information page/front-end page for Omokage search.
  • The word "yorodu" (or yorozu) is an old Japanese word meaning "ten thousand". "mi" (miru) is to see.

Related info.:EMDB / PDB / SASBDB / Comparison of 3 databanks / Yorodumi Search / Aug 31, 2016. New EM Navigator & Yorodumi / Yorodumi Papers / Jmol/JSmol / Function and homology information / Changes in new EM Navigator and Yorodumi

Read more